Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New Bacterial Target Identified for Early Detection of Noma

By LabMedica International staff writers
Posted on 01 Apr 2026

Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. More...

Without treatment, it is fatal in up to 90% of cases, and survivors face severe disfigurement and lifelong complications. Most cases are identified too late, when significant tissue damage has already occurred. Researchers now report a microbial discovery that could enable earlier diagnosis and more effective treatment.

Liverpool School of Tropical Medicine (LSTM) researchers, working with the University of Liverpool, Médecins Sans Frontières, and the Noma Children’s Hospital in Sokoto, Nigeria, applied shotgun metagenomic sequencing and machine-learning algorithms to saliva samples from children with acute noma. The analyses uncovered a previously undescribed Treponema species that was strongly associated with the disease. Treponema bacteria were also detected in early disease stages, suggesting they may play a key role in triggering progression from gingivitis to noma.

Further analysis indicated the identified bacteria did not harbor known antibiotic resistance genes, implying potential susceptibility to existing antibiotic treatments when detected early. The investigators also observed a disrupted oral microbiome in affected children, with Treponema taxa appearing more common and bacteria typical of a healthy mouth diminished. Together, these findings point to a consistent microbial signature for noma that could support earlier detection.

The research is published in PLOS Neglected Tropical Diseases. Noma was formally classified as a neglected tropical disease by the World Health Organization in 2023. According to the team, the discovery opens a path toward diagnostic tools that can identify the disease at its earliest stages, when treatment is most effective. The identification of a consistent microbial pattern marks a step forward in understanding this long-neglected condition and brings renewed hope for prevention, diagnosis, and treatment.

“We found that the composition of bacteria in children with noma is completely disrupted. Some bacteria, such as those in the Treponema genus, appear to be more common, while others that are usually part of a healthy mouth almost disappear. That imbalance gives us important clues about how the disease starts and progresses,” said Richard Goodman, joint lead author at Liverpool School of Tropical Medicine.

“Noma is a disease that simply should not exist, but up until now we have lacked a detailed understanding of the microbes involved. By using metagenomic sequencing, we can now see the full bacterial community in unprecedented detail. This has allowed us to identify a species of Treponema bacteria strongly linked to the disease,” said Adam Roberts, Professor at the Liverpool School of Tropical Medicine’s Center for Neglected Tropical Diseases.

Related Links
Liverpool School of Tropical Medicine (LSTM)


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.